Literature DB >> 33299110

A large-scale internal validation study of unsupervised virtual trichrome staining technologies on nonalcoholic steatohepatitis liver biopsies.

Joshua J Levy1,2,3, Nasim Azizgolshani4, Michael J Andersen5, Arief Suriawinata5, Xiaoying Liu5, Mikhail Lisovsky5, Bing Ren5, Carly A Bobak6,7,8,9, Brock C Christensen4,10,11, Louis J Vaickus5.   

Abstract

Non-alcoholic steatohepatitis (NASH) is a fatty liver disease characterized by accumulation of fat in hepatocytes with concurrent inflammation and is associated with morbidity, cirrhosis and liver failure. After extraction of a liver core biopsy, tissue sections are stained with hematoxylin and eosin (H&E) to grade NASH activity, and stained with trichrome to stage fibrosis. Methods to computationally transform one stain into another on digital whole slide images (WSI) can lessen the need for additional physical staining besides H&E, reducing personnel, equipment, and time costs. Generative adversarial networks (GAN) have shown promise for virtual staining of tissue. We conducted a large-scale validation study of the viability of GANs for H&E to trichrome conversion on WSI (n = 574). Pathologists were largely unable to distinguish real images from virtual/synthetic images given a set of twelve Turing Tests. We report high correlation between staging of real and virtual stains ([Formula: see text]; 95% CI: 0.84-0.88). Stages assigned to both virtual and real stains correlated similarly with a number of clinical biomarkers and progression to End Stage Liver Disease (Hazard Ratio HR = 2.06, 95% CI: 1.36-3.12, p < 0.001 for real stains; HR = 2.02, 95% CI: 1.40-2.92, p < 0.001 for virtual stains). Our results demonstrate that virtual trichrome technologies may offer a software solution that can be employed in the clinical setting as a diagnostic decision aid.

Entities:  

Year:  2020        PMID: 33299110      PMCID: PMC7985027          DOI: 10.1038/s41379-020-00718-1

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  59 in total

1.  Coding ordinal independent variables in multiple regression analyses.

Authors:  S D Walter; A R Feinstein; C K Wells
Journal:  Am J Epidemiol       Date:  1987-02       Impact factor: 4.897

2.  The cost-effectiveness of immunohistochemistry.

Authors:  S S Raab
Journal:  Arch Pathol Lab Med       Date:  2000-08       Impact factor: 5.534

3.  Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease.

Authors:  Amy G Shah; Alison Lydecker; Karen Murray; Brent N Tetri; Melissa J Contos; Arun J Sanyal
Journal:  Clin Gastroenterol Hepatol       Date:  2009-06-10       Impact factor: 11.382

4.  Evaluation of a Deep Neural Network for Automated Classification of Colorectal Polyps on Histopathologic Slides.

Authors:  Jason W Wei; Arief A Suriawinata; Louis J Vaickus; Bing Ren; Xiaoying Liu; Mikhail Lisovsky; Naofumi Tomita; Behnaz Abdollahi; Adam S Kim; Dale C Snover; John A Baron; Elizabeth L Barry; Saeed Hassanpour
Journal:  JAMA Netw Open       Date:  2020-04-01

5.  Mortality Related to Nonalcoholic Fatty Liver Disease Is Increasing in the United States.

Authors:  James M Paik; Linda Henry; Leyla De Avila; Elena Younossi; Andrei Racila; Zobair M Younossi
Journal:  Hepatol Commun       Date:  2019-08-14

6.  Whole Slide Imaging Versus Microscopy for Primary Diagnosis in Surgical Pathology: A Multicenter Blinded Randomized Noninferiority Study of 1992 Cases (Pivotal Study).

Authors:  Sanjay Mukhopadhyay; Michael D Feldman; Esther Abels; Raheela Ashfaq; Senda Beltaifa; Nicolas G Cacciabeve; Helen P Cathro; Liang Cheng; Kumarasen Cooper; Glenn E Dickey; Ryan M Gill; Robert P Heaton; René Kerstens; Guy M Lindberg; Reenu K Malhotra; James W Mandell; Ellen D Manlucu; Anne M Mills; Stacey E Mills; Christopher A Moskaluk; Mischa Nelis; Deepa T Patil; Christopher G Przybycin; Jordan P Reynolds; Brian P Rubin; Mohammad H Saboorian; Mauricio Salicru; Mark A Samols; Charles D Sturgis; Kevin O Turner; Mark R Wick; Ji Y Yoon; Po Zhao; Clive R Taylor
Journal:  Am J Surg Pathol       Date:  2018-01       Impact factor: 6.394

7.  Estimation of an inter-rater intra-class correlation coefficient that overcomes common assumption violations in the assessment of health measurement scales.

Authors:  Carly A Bobak; Paul J Barr; A James O'Malley
Journal:  BMC Med Res Methodol       Date:  2018-09-12       Impact factor: 4.615

Review 8.  Machine Learning Methods for Histopathological Image Analysis.

Authors:  Daisuke Komura; Shumpei Ishikawa
Journal:  Comput Struct Biotechnol J       Date:  2018-02-09       Impact factor: 7.271

9.  Topological Feature Extraction and Visualization of Whole Slide Images using Graph Neural Networks.

Authors:  Joshua Levy; Christian Haudenschild; Clark Barwick; Brock Christensen; Louis Vaickus
Journal:  Pac Symp Biocomput       Date:  2021

10.  Diagnostic concordance and discordance in digital pathology: a systematic review and meta-analysis.

Authors:  Ayesha S Azam; Islam M Miligy; Peter K-U Kimani; Heeba Maqbool; Katherine Hewitt; Nasir M Rajpoot; David R J Snead
Journal:  J Clin Pathol       Date:  2020-09-15       Impact factor: 3.411

View more
  3 in total

1.  Simple Code Implementation for Deep Learning-Based Segmentation to Evaluate Central Serous Chorioretinopathy in Fundus Photography.

Authors:  Tae Keun Yoo; Bo Yi Kim; Hyun Kyo Jeong; Hong Kyu Kim; Donghyun Yang; Ik Hee Ryu
Journal:  Transl Vis Sci Technol       Date:  2022-02-01       Impact factor: 3.283

Review 2.  Deep Learning Approaches and Applications in Toxicologic Histopathology: Current Status and Future Perspectives.

Authors:  Shima Mehrvar; Lauren E Himmel; Pradeep Babburi; Andrew L Goldberg; Magali Guffroy; Kyathanahalli Janardhan; Amanda L Krempley; Bhupinder Bawa
Journal:  J Pathol Inform       Date:  2021-11-01

3.  Topological Feature Extraction and Visualization of Whole Slide Images using Graph Neural Networks.

Authors:  Joshua Levy; Christian Haudenschild; Clark Barwick; Brock Christensen; Louis Vaickus
Journal:  Pac Symp Biocomput       Date:  2021
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.